In comparison to normal samples, the expressions of genes with deleted CNVs were found to be significantly decreased in AML samples (such as CEBPB, PLCG1, and VDR), and vice versa (such as TIRAP). This evidence concerns the gene CEBPB and acute myeloid leukemia.